Skip to main content

Table 1 Baseline characteristics of participants included in the PerfectFit-study according to organization ( n = 491)

From: Design and baseline characteristics of the PerfectFit study: a multicenter cluster-randomized trial of a lifestyle intervention in employees with increased cardiovascular risk

 

Organization 1

Organization 2

Organization 3

P value

(Police)

(Military)

(Hospital)

 

n = 262 (53 %)

n = 170 (35 %)

n = 59 (12 %)

 

Age, mean (sd)

52 (5.8)

49 (4.6)

53 (6.5)

<0.000*

Gender:

    

 Male

201 (82.7 %)

163 (98.2 %)

16 (27.6 %)

<0.000*

Educational level

    

 Low

39 (16.7 %)

16 (9.9 %)

11 (20 %)

<0.000*

 Medium

147 (63.1 %)

87 (53.7 %)

22 (40 %)

 

 High

47 (20.2 %)

59 (36.4 %)

22 (40 %)

 

Hypertensiona

78 (31.2 %)

73 (44.5 %)

22 (39.3 %)

0.021*

Body Mass Index category

    

 <25 kg/m2

62 (24.9 %)

34 (20.1 %)

32 (55.2 %)

<0.000*

 25-30 kg/m2

141 (56.6 %)

101 (59.8 %)

22 (37.9 %)

 >30 kg/m2

46 (18.5 %)

34 (20.1 %)

4 (6.9 %)

Waist circumference, cm :

    

 High (female >88 cm; male >102 cm)

100 (41.3 %)

71 (43.0 %)

30 (52.6 %)

0.299

Obesityb

104 (43.5 %)

75 (45.5 %)

30 (52.6 %)

0.462

Family history of CVDc

97 (37.6)

61 (39.4)

24 (42.9)

0.754

Diabetes mellitus (DM) type IId

10 (4.0)

3 (1.9)

1 (1.8)

0.408

Dyslipidemiae

238 (92.6 %)

154 (91.7 %)

56 (94.9 %)

0.715

Health risk behavior:

    

 Lack of physical activity

107 (42.0)

42 (26.9)

20 (37.0)

0.009*

 Smoking

42 (16.5)

27 (16.9)

3 (5.4)

0.088

Framingham 10-year CVD risk score categoryf

    

 Low (<10 %)

153 (66.5 %)

120 (78.9 %)

32 (58.2 %)

0.003*

 Intermediate (≥10 %, <20 %)

68 (29.6 %)

22 (14.5 %)

20 (36.4 %)

 High (≥20 %)

9 (3.9 %)

10 (6.6 %)

3 (5.5 %)

Number of inclusion criteria:

    

 1

51 (19.8 %)

26 (15.4 %)

7 (11.9 %)

0.235

 2

68 (26.5 %)

62 (36.7 %)

21 (35.6 %)

 

 3

77 (30.0 %)

43 (25.4 %)

20 (33.9 %)

 

 ≥4

61 (23.7 %)

38 (22.5 %)

11 (18.6 %)

 
  1. *statistically different, continuous measurements based on ANOVA test and categorical measurements based on Chi-Square test
  2. aHypertension is defined as diastolic blood pressure higher than 90 mmHG or systolic blood pressure higher than 140mmHG or taking antihypertensive drugs
  3. bObesity is defined as BMI >30 kg/m2 or waist circumference >88 cm for females or >102 cm for males
  4. cFamily history of CVD is defined as a first degree family member who suffered a CVD at any age
  5. dDiabetes is defined as having a sober blood glucose higher than 6.1 or self-reported diagnosis of diagnosis
  6. eDyslipidemia is defined as having increased levels of at least one type of lipids in the blood (total cholesterol ≥ 5 mmol/l, or LDL cholesterol ≥ 2.5 mmol/l; or triglycerides: ≥ 1.7,mmol/l, or HDL cholesterol: ≤ 1.0 mmol/l)
  7. fEuroSCORE and QRISK2 will be calculated after completion of the intervention, at 12 months